What should be done about mephedrone?

  title={What should be done about mephedrone?},
  author={Adam R Winstock and John Marsden and Luke Mitcheson},
  journal={BMJ : British Medical Journal},
We should focus on crafting the most effective public health response 
The war on drugs
Does prohibition work?
The intensive care management of common and uncommon drugs of misuse.
With an ever-expanding field of illicit drugs available, doctors working in the acute specialties will inevitably be involved in the management of the serious and life-threatening side effects of
Mephedrone: when science and policy fell out
Mephedrone is a stimulant drug of abuse whose public profile rose dramatically in 2009. At that time, it was designated as ‘legal high’ and was predominantly sold over the Internet for as little as
‘Legal Highs’: The Challenge of New Psychoactive Substances
This paper aims to set out some of the policy and public health issues raised by the appearance of a wide range of emergent psychoactive substances of diverse origin, effect and risk profile
Mephedrone toxicity in a Scottish emergency department
A profile of largely psychoactive and cardiovascular toxicity is described with drug naivety perhaps explaining the high rates of bingeing and addiction reported.
Options for regulating new psychoactive drugs: a review of recent experiences.
This paper is intended to provide the basis for a discussion of policy options in dealing with new psychoactive substances that show signs of popularity and of harmfulness within a wider project
The confusing case of NRG-1
Since the recent ban on mephedrone, several alternative products have been introduced on internet websites and one of the most prominently discussed second generation products is NRG-1, also advertised as naphyrone, which originated from a group of compounds previously described in the medicinal chemistry.
Deaths of individuals aged 16–24 years in the UK after using mephedrone
This study aims to analyse fatalities following ingestion of mephedrone in the UK amongst 16‐ to 24‐year‐olds in 2009–2013, providing an update on data presented at the 2nd International Conference on Novel Psychoactive Substances.
A systematic review of methamphetamine precursor regulations.
Methamphetamine precursor regulations can reduce indicators of methamphetamine supply and use and further research is needed to determine whether regulations can be effective outside North America, particularly in developing countries, and what impact they have on the broader synthetic drug market.


Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition
Significant changes in British recreational drug use were seen throughout 2009, with the emergence and rapid growth in the availability and use of substituted cathinones or ‘M‐Cats’ (most notably
Overview of Amphetamine-Type Stimulant Mortality Data – UK, 1997–2007
With respect to AMP/METH, ecstasy was here more typically identified in victims who were young, healthy, and less likely to be known as drug users; excess ecstasy-related fatality rates in young users may be a reason for concern.
The annual Mixmag drugs survey
  • 2010
Drug-related deaths in the UK. Annual report 2009. International Centre for Drug Policy
  • 2009
Mephedrone: use of mephedrone (M-cat, Meow) in Middlesbrough
  • 2009
Recreational use of 4-methylmethcathinone (4-MMC) presenting with sympathomimetic toxicity and confirmed by toxicological screening [abstract
  • Abstracts of the 2009 North American Congress of Clinical Toxicology annual meeting
  • 2009
Kalix 1992 Cathinone, a natural amphetamine
  • Pharmacol Toxicol
  • 1992